These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29240228)

  • 1. Chromatographic methods in HIV medicine: Application to therapeutic drug monitoring.
    Archibald TL; Murrell DE; Brown SD
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 29240228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the monitoring of temsavir plasma concentrations in people living with HIV.
    Thoueille P; Seybold U; Decosterd LA; Desfontaine V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123575. PubMed ID: 36542988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Chromatographic Methods Coupled with Modern Detection Techniques Applied in the Therapeutic Drugs Monitoring (TDM).
    Tuzimski T; Petruczynik A
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32899296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
    Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
    Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS application for therapeutic drug monitoring in alternative matrices.
    Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A
    J Pharm Biomed Anal; 2019 Mar; 166():40-51. PubMed ID: 30609393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.
    Ghareeb M; Akhlaghi F
    Bioanalysis; 2015; 7(8):1037-58. PubMed ID: 25966013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a potential drug-drug interaction.
    Belkhir L; De Laveleye M; Vandercam B; Zech F; Delongie KA; Capron A; Yombi J; Vincent A; Elens L; Haufroid V
    Clin Biochem; 2016 May; 49(7-8):580-6. PubMed ID: 26742721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma.
    Grégoire M; Deslandes G; Renaud C; Bouquié R; Allavena C; Raffi F; Jolliet P; Dailly E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():1-9. PubMed ID: 25261833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.
    Punyawudho B; Singkham N; Thammajaruk N; Dalodom T; Kerr SJ; Burger DM; Ruxrungtham K
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1583-1595. PubMed ID: 27626677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring and LC-MS/MS.
    Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():33-49. PubMed ID: 21992751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells.
    Elens L; Veriter S; Yombi JC; Di Fazio V; Vanbinst R; Lison D; Wallemacq P; Vandercam B; Haufroid V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1805-14. PubMed ID: 19487167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.
    Marinova M; Artusi C; Brugnolo L; Antonelli G; Zaninotto M; Plebani M
    Clin Biochem; 2013 Nov; 46(16-17):1723-7. PubMed ID: 24012696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry.
    Koal T; Burhenne H; Römling R; Svoboda M; Resch K; Kaever V
    Rapid Commun Mass Spectrom; 2005; 19(21):2995-3001. PubMed ID: 16193530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
    Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in antifungal drug measurement by liquid chromatography-mass spectrometry.
    Zheng YZ; Wang S
    Clin Chim Acta; 2019 Apr; 491():132-145. PubMed ID: 30685359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV.
    Martin J; Deslandes G; Dailly E; Renaud C; Reliquet V; Raffi F; Jolliet P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3072-82. PubMed ID: 19699694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefit of interventions driven by therapeutic drug monitoring.
    Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
    HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncology.
    van Nuland M; Rosing H; Schellens JHM; Beijnen JH
    Biomed Chromatogr; 2020 Jan; 34(1):e4623. PubMed ID: 31215049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.